Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
CRON
BuyPremium GrowerCronos Group Inc. · Healthcare · Canada · $1.2B · Avg Vol: $5M/d
COMPANY DESCRIPTION
Cronos Group Inc. is a global cannabinoid company engaged in the cultivation, production, and marketing of cannabis and hemp-derived products for medical and recreational markets. A significant strategic investment and partnership with Altria Group provides a strong competitive moat through enhanced capital, distribution channels, and research capabilities, positioning it for leadership in the evolving cannabis industry.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 86.7M | 87.2M | 117.6M | 146.6M | 19.1% | 179.1M | 203.8M | 235.9M | 26.9% |
| EPS | -0.45 | -0.19 | 0.11 | -0.02 | — | 0.19 | 0.22 | 0.16 | 12.9% |
| Shares | 380.6M | 381.3M | 382.5M | 381.6M | +0.3% | 368.4M | — | — | — |
| Debt | 3.9M | 2.6M | 2.0M | 1.5M | -27.0% | 1.3M | — | — | — |
| Equity | 1.1B | 1.1B | 1.1B | 1.1B | -1.5% | — | — | — | — |
| Op CF | -88.9M | -42.8M | 18.8M | 25.9M | 37.3% | 60.1M | — | — | — |
| Inv CF | -1.8M | -59.5M | 175.1M | -76.6M | — | — | — | — | — |
| Fin CF | -2.9M | -1.0M | -1.2M | -19.9M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of CRON are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| CRON | Cronos Group Inc.(you) | $1.2B | 68 | Buy |
| GUD.TO | Knight Therapeutics Inc. | $682M | 76 | Buy |
| BHC.TO | Bausch Health Companies Inc. | $2.5B | 86 | Strong Buy |
| TSND.TO | TerrAscend Corp. | $243M | 60 | Hold |
| OGI.TO | Organigram Global Inc. | $171M | 66 | Buy |
| APTX.TO | Apotex Health Corp. | $5.4B | 46 | Hold |
| CPH.TO | Cipher Pharmaceuticals Inc. | $265M | 92 | Strong Buy |
| HLS.TO | HLS Therapeutics Inc. | $80M | 66 | Buy |
| ACB.TO | Aurora Cannabis Inc. | $253M | 40 | Hold |
| XLY.TO | Auxly Cannabis Group Inc. | $232M | 98 | Strong Buy |
Peer medians: ROE -37.9% · P/E 18.1x · Gross margin 46.2%